Dr. Arun Upadhyay is a chief scientific officer and head of
Research, Development, and Medical at Ocugen, Inc. He completed his PhD studies
in biotechnology at the National Institute of Immunology, India. He oversees
the development of various product modalities, such as biologics, vaccines,
cell and gene therapy, and regenerative medicine. He was awarded the American
Association of Pharmaceutical Scientists’ “Innovation in Nanotechnology Award”
for developing novel ocular drug delivery systems. He has authored more than 40
scientific publications and holds more than 15 patents.
Dr. Arun Upadhyay is a chief scientific officer and head of
Research, Development, and Medical at Ocugen, Inc. He completed his PhD studies
in biotechnology at the National Institute of Immunology, India. He oversees
the development of various product modalities, such as biologics, vaccines,
cell and gene therapy, and regenerative medicine. He was awarded the American
Association of Pharmaceutical Scientists’ “Innovation in Nanotechnology Award”
for developing novel ocular drug delivery systems. He has authored more than 40
scientific publications and holds more than 15 patents.